MARKET

SLDB

SLDB

Solid Bioscience
NASDAQ
6.49
-0.62
-8.72%
Closed 18:02 03/30 EDT
OPEN
7.11
PREV CLOSE
7.11
HIGH
7.11
LOW
6.40
VOLUME
1.24M
TURNOVER
--
52 WEEK HIGH
8.72
52 WEEK LOW
2.410
MARKET CAP
638.56M
P/E (TTM)
-3.2577
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SLDB last week (0323-0327)?
Weekly Report · 23h ago
Solid Biosciences Is Maintained at Overweight by JP Morgan
Dow Jones · 5d ago
Solid Biosciences Price Target Raised to $12.00/Share From $11.00 by JP Morgan
Dow Jones · 5d ago
JP Morgan Maintains Overweight on Solid Biosciences, Raises Price Target to $12
Benzinga · 5d ago
J.P. Morgan Issues a Buy Rating on Solid Biosciences (SLDB)
TipRanks · 5d ago
Solid Biosciences price target raised to $12 from $11 at JPMorgan
TipRanks · 5d ago
3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts
TipRanks · 03/23 15:07
Analysts Offer Insights on Healthcare Companies: Beta Bionics, Inc. (BBNX), Apogee Therapeutics (APGE) and Solid Biosciences (SLDB)
TipRanks · 03/23 12:50
More
About SLDB
Solid Biosciences Inc. is a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases. The Company is focused on advancing a portfolio of gene therapy candidates including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy and additional assets for the treatment of genetic cardiac and neuromuscular disease. It also has two cardiac pipeline gene transfer programs, SGT-401 for BAG3-mediated DCM, which is in early preclinical development, and SGT-701 for RBM20 DCM, which is in the discovery stage. In addition to its gene transfer candidates, the Company has development programs focusing on platform technologies, including capsid libraries and dual gene expression, a technology that allows it to package multiple transgenes into one capsid.

Webull offers Solid Biosciences Inc stock information, including NASDAQ: SLDB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SLDB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SLDB stock methods without spending real money on the virtual paper trading platform.